GoodRx Holdings, Inc. (GDRX)
Pre-market:
| Previous close | 6.96 |
| Open | 6.83 |
| Bid | 7.06 x 400 |
| Ask | 7.09 x 200 |
| Day's range | 6.80 - 7.09 |
| 52-week range | 4.14 - 9.37 |
| Volume | |
| Avg. volume | 1,319,211 |
| Market cap | 2.797B |
| Beta (5Y monthly) | 1.43 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.02 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 8.76 |
Business WireGoodRx Announces Date for 2024 Investor Day
SANTA MONICA, Calif., April 24, 2024--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., today announced it will hold its first Investor Day on May 15, 2024, in New York City. The event will begin at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Time).
ZacksIs GoodRx (GDRX) Outperforming Other Medical Stocks This Year?
Here is how GoodRx Holdings, Inc. (GDRX) and Amplifon S.p.A. (AMFPF) have performed compared to their sector so far this year.
Business WireGoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call
SANTA MONICA, Calif., April 11, 2024--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., today announced it will release its first quarter 2024 financial results before U.S. markets open on Thursday, May 9, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook.
